奧托立夫 ALV 深滬

等待開盤 11-03 09:30:00 美东时间

116.80

+0.450

+0.39%

華盛通

立即下載

最高116.995
今開116.12
成交量 52.79万股
最低 115.0025
昨收 116.35
總市值 89.71亿
52周最高 129.54
市盈率 ^靜 14.54
換手率 0.00%
52周最低 73.94
委比 -40.00%
總股本 7680.72万
歷史最高 129.54
量比 0.83
振幅 1.71%
歷史最低 -22.69
每手 1
風險率 13.26%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

常熟加码汽车电子产业

（来源：新华日报） □ 本报记者韩雷一向敢为人先的常熟，再次迈出关键一步。 10月28日，常熟启动汽车电子产业全球伙伴行动，盛邀全球行业翘楚、领军企...

10-31 06:34
Insights into Magna International's Upcoming Earnings

Magna International (NYSE:MGA) is set to give its latest quarterly earnings rep...

10-30 23:02
Autoliv Issues EUR 300 Million Notes for Sustainability

Autoliv ( ($ALV) ) just unveiled an update. On October 29, 2025, Autoliv, Inc. ...

10-29 19:51
Alvo Minerals Advances Touro Prospect as Priority Drill Target

Alvo Minerals Limited ( ($AU:ALV) ) has issued an update. Alvo Minerals Limited...

10-28 08:17
Alvotech Announces Changes in Global Business Development and Commercial Operations Team

Alvotech announced changes to its global business development and commercial operations team. Anil Okay is stepping down as Chief Commercial Officer to lead Adalvo. Trisha Durant has joined as Senior Vice President, Global Business Development and Commercial Operations, ex-North America. Harshika Sarbajna is now Senior Vice President Commercial, North America. Agne Pasko has been appointed Vice President Head of Business Development. Róbert Wessm...

10-22 09:00
美股大行评级 | 潜在涨幅344.44%！Rani Therapeutics获Maxim Group升目标价至10美元，维持"买入"评级

今日重点评级关注：Maxim Group：维持Rani Therapeutics Hldgs"买入"评级，目标价从5美元升至10美元；韦德布什：维持Corbus Pharmaceuticals"跑赢大市"评级，目标价从31美元升至38美元

10-21 18:13
Wells Fargo Maintains Equal-Weight on Autoliv, Lowers Price Target to $129

Wells Fargo analyst Colin Langan maintains Autoliv (NYSE:ALV) with a Equal-Weight and lowers the price target from $132 to $129.

10-20 21:38
电话会总结｜ Autoliv(ALV)2025财年Q3业绩电话会核心要点

编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。<blockquote>业绩回顾</blockquote>• 根据Autoliv (ALV)的业绩会实录,我总结如下: • 财务业绩: - 第三季度净销售额为27亿美元 - 调整后营业利润为2.71亿美元 - 毛利率为19.3% - 经营现金流为2.58亿美元 - 自由经营现金流为1.53亿美元 - 调整后每股收益为1.48美元 • 财务指标变化: - 净销售额同比增长6%,有机销售增长4% - 调整后营业利润同比增长14% - 毛利率同比提高130个基点 - 调整后营业利润率为10.0%,同比提高70个基点 - 经营现金流同比增长46% - 自由经营现金流

10-18 12:03
Why Is Protalix BioTherapeutics Stock Falling On Friday?

EMA issues a negative opinion on Protalix and Chiesi's Elfabrio revised dosing for Fabry disease, citing insufficient data to confirm efficacy.

10-17 23:23
Rani Teams Up With Chugai To Revolutionize Oral Drug Delivery For Rare Diseases

Rani Therapeutics (NASDAQ: RANI) stock surged on licensing collaboration with Chugai and $60.3M private placement. RANI up 191.99% at $1.375.

10-17 21:45

派息除權日	每股總股息	派息日期
2025-09-05	0.85	2025-09-23
2025-05-21	0.70	2025-06-10
2025-03-07	0.70	2025-03-24
2024-12-03	0.70	2024-12-19
2024-09-04	0.68	2024-09-23
2024-05-22	0.68	2024-06-12
2024-03-11	0.68	2024-03-27
2023-11-27	0.68	2023-12-13
2023-09-06	0.66	2023-09-22
2023-05-24	0.66	2023-06-13
2023-03-07	0.66	2023-03-23
2022-11-21	0.66	2022-12-09
2022-09-06	0.64	2022-09-22
2022-05-23	0.64	2022-06-13
2022-03-07	0.64	2022-03-23
2021-11-26	0.64	2021-12-13
2021-09-08	0.62	2021-09-24
2021-05-27	0.62	2021-06-14
2020-05-18	0.62	2020-06-04
2020-02-19	0.62	2020-03-05
2019-11-19	0.62	2019-12-05
2019-08-20	0.62	2019-09-05
2019-05-21	0.62	2019-06-07
2019-02-21	0.62	2019-03-07
2018-11-20	0.62	2018-12-06
2018-08-21	0.62	2018-09-06
2018-05-22	0.62	2018-06-07
2018-02-21	0.60	2018-03-08
2017-11-21	0.60	2017-12-07
2017-08-21	0.60	2017-09-07
2017-05-15	0.60	2017-06-01
2017-02-13	0.58	2017-03-02
2016-11-14	0.58	2016-12-01
2016-08-16	0.58	2016-09-01
2016-05-16	0.58	2016-06-02
2016-02-16	0.56	2016-03-03
2015-11-16	0.56	2015-12-03
2015-08-18	0.56	2015-09-03
2015-05-18	0.56	2015-06-04
2015-02-17	0.54	2015-03-05
2014-11-17	0.54	2014-12-04
2014-08-18	0.54	2014-09-04
2014-05-19	0.52	2014-06-05
2014-02-18	0.52	2014-03-06
2013-11-18	0.50	2013-12-05
2013-08-19	0.50	2013-09-05
2013-05-20	0.50	2013-06-07
2013-02-19	0.50	2013-03-07
2012-11-19	0.50	2012-12-06
2012-08-20	0.47	2012-09-06
2012-05-21	0.47	2012-06-07
2012-02-13	0.45	2012-03-01
2011-11-15	0.45	2011-12-01
2011-08-16	0.45	2011-09-01
2011-05-03	0.43	2011-06-02
2011-02-01	0.40	2011-03-03
2010-11-02	0.35	2010-12-09
2010-08-03	0.30	2010-09-02
2009-02-03	0.21	2009-03-05
2008-11-04	0.41	2008-12-04
2008-08-05	0.41	2008-09-04
2008-05-06	0.39	2008-06-05
2008-02-05	0.39	2008-03-06
2007-11-06	0.39	2007-12-06
2007-08-07	0.39	2007-09-06
2007-05-08	0.39	2007-06-07
2007-01-30	0.37	2007-03-01
2006-11-07	0.37	2006-12-07
2006-08-08	0.35	2006-09-07
2006-05-02	0.32	2006-06-01
2006-01-31	0.32	2006-03-02
2005-11-08	0.32	2005-12-08
2005-08-09	0.30	2005-09-08
2005-05-02	0.30	2005-06-02
2005-02-01	0.25	2005-03-03
2004-11-08	0.20	2004-12-09
2004-08-10	0.20	2004-09-09
2004-05-04	0.20	2004-06-03
2004-02-03	0.15	2004-03-04
2003-11-04	0.15	2003-12-04
2003-08-05	0.13	2003-09-04
2003-05-02	0.13	2003-06-05
2003-02-04	0.13	2003-03-06
2002-11-05	0.11	2002-12-05
2002-08-06	0.11	2002-09-05
2002-05-06	0.11	2002-06-06
2002-02-05	0.11	2002-03-07
2001-11-06	0.11	2001-12-06
2001-08-07	0.11	2001-09-06
2001-05-08	0.11	2001-06-07
2001-01-30	0.11	2001-03-01
2000-11-07	0.11	2000-12-07
2000-08-08	0.11	2000-09-07
2000-05-04	0.11	2000-06-05
2000-02-01	0.11	2000-03-02
1999-11-02	0.11	1999-12-02
1999-08-03	0.11	1999-09-02
1999-05-04	0.11	1999-06-03
1999-02-02	0.11	1999-03-04
1998-11-03	0.11	1998-12-03
1998-08-04	0.11	1998-09-03
1998-05-05	0.11	1998-06-04
1998-02-03	0.11	1998-03-05
1997-11-04	0.11	1997-12-04
1997-08-05	0.11	1997-09-04

公司名稱	奥托立夫
行業分類	汽车零部件
業務描述	Autoliv, Inc. is a holding company, which engages in the development, manufacture, and supply of automotive safety systems. Its products include airbags, seatbelts, steering wheels, inflators and initiators, textiles and webbing, commercial vehicle and electrical safety solutions, motorcycles and bikes, pedestrian protection, and test services. The company was founded by Lennart Lindblad in 1953 and is headquartered in Stockholm, Sweden.

奧托立夫 ALV 深 滬

116.80

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

奧托立夫 ALV 深滬